JamesLinChenMD

Oncology • Columbus, OH

Hematologic Oncology, Sarcoma, Clinical Informatics

Associate Professor, The Ohio State & SVP Cancer Informatics, Tempus Labs

Join to view full profile

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chen's full profile

Already have an account?

Office
460 W 10th Ave
Columbus, OH 43210
Phone+1 614-293-6529

Fax+1 614-293-9469

Education & Training

Rutgers New Jersey Medical SchoolClass of 2005

Certifications & Licensure

OH State Medical License 2012 - 2025
IL State Medical License 2008 - 2014
DC State Medical License 2005 - 2008
VA State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

22 citations
Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
Alice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, Nancy Moore, Jared C Foster
The New England Journal of Medicine. 2023-09-07
1212 citations
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20
1 citations
Evolving From Discrete Molecular Data Integrations to Actionable Molecular Insights Within the Electronic Health Record.
James L Chen, Martin C Stumpe, Ezra Cohen
JCO Clinical Cancer Informatics. 2024-04-01

Journal Articles

The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources
James L Chen, John L Hays, Yearbook of Medical Informatics
Loss of TXNIP Enhances Peritoneal Metastasis and Can Be Abrogated by Dual TORC1/2 Inhibition
David Cohen, James L Chen, John L Hays, Oncotarget

Abstracts/Posters

An All Antibody Approach for Conditioning Bone Marrow for Hematopoietic Stem Cell Transplantation with Anti-cKIT and Anti-CD47 in Non-Human Primates
James Y Chen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Deriving real-world oral antineoplastic treatment endpoints: A comparison of automated data extraction versus manual chart abstraction.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Tempus Announces Three Abstracts Accepted for Presentation at the European Society for Medical OncologySeptember 12th, 2022
Tempus Announces 14 Abstracts Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting 2022June 6th, 2022
Inhibition of Histone Deacetylase 2 Reduces MDM2 Expression and Reduces Tumor Growth in Dedifferentiated LiposarcomaOctober 4th, 2019

Professional Memberships